stars 1 stars 2 stars 3

StemRIM is a drug discovery research and development-oriented biotech company originating from Osaka University. It was established in 2006 with the aim of developing a myelomulti-active stem cell recruitment factor as a pharmaceutical product, which was identified by Professor Tamai and his colleagues at the Graduate School of Medicine, Osaka University. Since then, through joint research with Osaka University, StemRIM has been consistently worked on the development of "regeneration-inducing medicine", which is medicine promoting functional tissue regeneration and enabling the treatment of intractable diseases. StenRIM is continuing to take on the challenge of becoming a world-leading bioventure with the corporate mission of "overcoming intractable diseases with regeneration-inducing medicine.

Stemrim Questions

The Stemrim annual revenue was $21.4 million in 2026.

1 people are employed at Stemrim.

The NAICS codes for Stemrim are [54171, 541, 54, 5417, 541713].

The SIC codes for Stemrim are [87, 873].

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users